0
The European Union has officially launched the Partnership on One Health Antimicrobial Resistance (OHAMR). Co-funded by Horizon Europe with €75 million, this ambitious 10-year programme tackles the urgent global health threat of antimicrobial resistance (AMR).
Coordinated by the Swedish Research Council, OHAMR brings together 53 organisations from 30 countries, and it uses a One Health approach to connect sectors and accelerate solutions reducing antimicrobial use and resistance. Activities planned under the partnership include:
- Joint transnational calls for collaborative research and innovation projects;
- Strengthening research capacity in participating countries;
- Promoting the translation of knowledge into practice and policy;
- Supporting access to and better use of data on AMR;
- Increasing impact through coordination and alignment of national and European efforts.
This partnership will contribute to the implementation of the Strategy for European Life Sciences by promoting a One Health approach that recognizes the interconnectedness of human, animal, and environmental health, a key principle outlined in the strategy. By supporting the development and market uptake of innovative tools to tackle AMR, this partnership will help achieve the strategy's objective to position the EU as the world’s most attractive place for life sciences by 2030.
September 23, 2025/ European Commission/ Euorpean Union.
https://research-and-innovation.ec.europa.eu/
